INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46m ago
House PTR6m ago
SEC 13F5m ago
Robinhood Chain5m ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Grant or award
A—
58.1K sh
Sep 9, 2026Sep 11, 2026
Page 368 of 1689
← PrevNext →
traded Sep 9, 2026
+2d
SEC Form 4

Evidence

9
LA
Lumpkin AlexandraChief Legal Officer
REAXReal REMAX Group Inc.
Grant or award
A—
31.3K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
VV
Venkatesh VandanaEVP and Chief Legal Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,277
90 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
ZS
Zahnd SaschaDirector
LOGILOGITECH INTERNATIONAL S.A.
Tax withholding
F$13K
136 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
PS
Pandit SumitaChief Financial Officer
GGenpact LTD
Grant or award
A—
76.7K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
IK
Iyengar Vijay KDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
76.1K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
SS
Subramanian SanjayChief Financial Officer
SCYXSCYNEXIS INC
Grant or award
A—
100.0K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Option exercise
M—
4,400 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
DJ
Dolan John JosephChief Financial Officer
EHTHeHealth, Inc.
Tax withholding
F$5,390
5,859 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
6,547 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
NF
North John FDirector
XPELXPEL, Inc.
Option exercise
M—
441 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
BM
Barbeau Michelle MarieChief Revenue Officer
EHTHeHealth, Inc.
Tax withholding
F$3,967
4,312 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
MK
Moen KirstenChief Operating Officer
SHLSShoals Technologies Group, Inc.
Tax withholding
F$20K
2,790 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
OM
Olsen Kevin M.Director, President and CEO
DORMDorman Products, Inc.
Option exercise
M—
11.7K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
2,797 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
BA
Boehme AlanDirector
LOVELovesac Co
Grant or award
A—
5,238 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
JR
Jani RaviChief Financial Officer
REAXReal REMAX Group Inc.
Grant or award
A—
27.5K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
JK
Jenkins Norman K.Director
REAXReal REMAX Group Inc.
Grant or award
A—
4,914 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
HJ
Hernandez Jacinto JChief Financial Officer
CDZICADIZ INC
Grant or award
A—
800.0K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
BD
Berger DietmarChief Medical Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
533 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
HJ
Hernandez Jacinto JChief Financial Officer
CDZICADIZ INC
Grant or award
A—
800.0K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
MH
Meyer Seth HPresident
HTGCHercules Capital, Inc.
Tax withholding
F$88.05
5 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
PG
Phillips GeoffreySr. VP, Operations
GATXGATX CORP
Option exercise
M—
2,500 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

9
BE
Bugnion EdouardDirector
LOGILOGITECH INTERNATIONAL S.A.
Tax withholding
F$14K
138 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
DP
Damani PriteshChief Technology Officer
REAXReal REMAX Group Inc.
Grant or award
A—
58.2K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
CM
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp
GILDGILEAD SCIENCES, INC.
Option exercise
M—
590 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
BA
Boehme AlanDirector
LOVELovesac Co
Option exercise
M—
5,238 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Option exercise
M—
7,729 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
NW
Ng Kwok WangDirector
LOGILOGITECH INTERNATIONAL S.A.
Tax withholding
F$13K
136 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
77 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
CM
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp
GILDGILEAD SCIENCES, INC.
Tax withholding
F$41K
285 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
BD
Berger DietmarChief Medical Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$38K
263 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

9
SL
Stillwell Mary-LeeSVP and Controller
VZVERIZON COMMUNICATIONS INC
Grant or award
A$585
41 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

8
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$195K
1,347 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

8
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Option exercise
M$128K
6,600 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

8
MS
Musunuri ShankarDirector, Chief Executive Officer
OCGNOcugen, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
57.3K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

8
BB
Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER
DGICADONEGAL GROUP INC
Option exercise
M$120K
8,326 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

8
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Option exercise
M$76K
4,400 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$273K
505 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$280K
520 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence